FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival

ABSTRACT Background FXYD3 is a Na/K‐ATPase modulator which is upregulated in pancreatic ductal adenocarcinoma (PDAC), but its prognostic role is unknown. This study evaluated FXYD3 expression in chemo‐naive patients with surgically‐resected PDAC at a single centre (1993–2014). Method FXYD3 expressio...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Nathalie B. Rasko, Christopher B. Nahm, John Turchini, Rachel Teh, Helge Rasmussen, Sooin Byeon, Sumit Sahni, Jaswinder S. Samra, Anthony J. Gill, Anubhav Mittal
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2025-01-01
Cyfres:	Cancer Medicine
Pynciau:	FXYD3 MAT‐8 pancreatic cancer pancreatic ductal adenocarcinoma prognosis survival
Mynediad Ar-lein:	https://doi.org/10.1002/cam4.70500
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!